| Fund ID | 805-4671570875 |
| Fund type | Hedge Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | No |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | Yes |
| Relies on exemption from registration | No |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| Sales limited to qualified investors | No |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 6% |
| Owned by funds of funds | 50% |
| Owned by non-U.S. persons | 0% |
| Fund | Type | Gross assets |
|---|---|---|
| Driehaus Emerging Markets Fund, L.P. | Other Private | $359.3M |
| Driehaus Life Sciences Master Fund, L.P. | Hedge | $302.3M |
| Driehaus Life Sciences (qp) Fund, L.P. | Hedge | $109.7M |
Driehaus Associates Fund reports $9.5 million in gross assets, among the top 78% of private funds by size.
The stated minimum investment is $50,000.
Driehaus Associates Fund is managed by Driehaus Capital Management LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.